nad has been researched along with pyrazinamide in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (57.89) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, K | 1 |
| Aoki, N; Inoue, K; Sanada, H; Wada, O | 1 |
| Abeles, RH; Alston, TA | 1 |
| Hada, T; Higashino, K; Moriwaki, Y; Takahashi, S; Yamamoto, T | 1 |
| Bekierkunst, A; Bricker, A | 1 |
| Dulin, WE; Wyse, BM | 1 |
| Toida, I | 2 |
| Protivinsky, R | 1 |
| Berger, NA; Berger, SJ; Catino, DM; Sikorski, GW; Sims, JL | 1 |
| Imai, H; Nasu, S; Sakakibara, S; Ueda, I; Yamaguchi, K | 1 |
| Higashino, K; Moriwaki, Y; Suda, M; Takahashi, S; Yamamoto, T | 1 |
| Iwamoto, N; Sano, K; Shin, M; Umezawa, C; Yamashita, M | 1 |
| Fukuwatari, T; Shibata, K; Sugimoto, E | 2 |
| Egashira, Y; Sanada, H; Sato, M; Shin, M; Sugawara, R; Tanabe, A | 1 |
| Attalla, SM; Carter, WG; Christie, D; Elmorsy, E; Fikry, E; Kocon, A; Nwidu, LL; Turner, R; Warren, A | 1 |
| Dartois, V; Dick, T; Gopal, P; Grüber, G; Kaya, F; Manimekalai, MSS; Nartey, W; Ragunathan, P; Sarathy, J; Setzer, C; Yee, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
1 review(s) available for nad and pyrazinamide
| Article | Year |
|---|---|
Chemotherapeutics with tuberculostatic action.
Topics: Aminosalicylic Acids; Antitubercular Agents; Catalase; Ethambutol; Ethionamide; Hemin; Humans; Hydrogen Peroxide; Isoniazid; Isonicotinic Acids; Metals; NAD; Pyrazinamide; Structure-Activity Relationship; Thiosemicarbazones | 1971 |
1 trial(s) available for nad and pyrazinamide
| Article | Year |
|---|---|
Xylitol-induced increase in the concentration of oxypurines and its mechanism.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Cytosol; Humans; Hypoxanthine; Hypoxanthines; Infusions, Intravenous; Inosine; Intestine, Small; Lactates; Lactic Acid; Liver; Male; Middle Aged; NAD; Phosphates; Pyrazinamide; Pyruvates; Pyruvic Acid; Saline Solution, Hypertonic; Serum Albumin; Uric Acid; Xanthine; Xanthine Dehydrogenase; Xanthines; Xylitol | 1995 |
17 other study(ies) available for nad and pyrazinamide
| Article | Year |
|---|---|
[Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
Topics: Adenoma, Islet Cell; Amides; Animals; Blood Glucose; Cats; Cystine; Deoxyglucose; Diabetes Mellitus; Dimethylnitrosamine; Fatty Acids, Nonesterified; Glutathione; Guinea Pigs; Insulin; Islets of Langerhans; Male; Mannoheptulose; Mice; NAD; Niacinamide; Nicotinic Acids; Pancreatic Neoplasms; Picolinic Acids; Pyrazinamide; Rabbits; Rats; Streptozocin; Tolbutamide; Uric Acid | 1975 |
Effects of dietary pyrazinamide, tryptophan, or nicotinic acid and gamma-ray irradiation on levels of NAD and NADP in various organs of mice.
Topics: Animals; Eating; Female; Gamma Rays; Mice; Mice, Inbred C3H; NAD; NADP; Niacin; Organ Specificity; Pyrazinamide; Thymus Gland; Tryptophan | 1989 |
Substrate specificity of nicotinamide methyltransferase isolated from porcine liver.
Topics: Animals; Glycerol; Hydrogen-Ion Concentration; Isoquinolines; Liver; Methyltransferases; Molecular Weight; NAD; Niacinamide; Nicotinamide N-Methyltransferase; Pyrazinamide; Pyridines; Quinolines; Substrate Specificity; Sulfhydryl Compounds; Swine; Tetrahydroisoquinolines | 1988 |
In vitro conversion of pyrazinamide into 5-hydroxypyrazinamide and that of pyrazinoic acid into 5-hydroxypyrazinoic acid by xanthine oxidase from human liver.
Topics: Humans; Liver; NAD; Pyrazinamide; Xanthine Oxidase | 1987 |
Studies on the mode of action of isoniazid on mycobacteria.
Topics: Aminosalicylic Acids; Drug Resistance, Microbial; Hot Temperature; Isoniazid; Mycobacterium tuberculosis; N-Glycosyl Hydrolases; NAD; Pyrazinamide; Streptomycin | 1967 |
Studies on the ability of compounds to block the diabetogenic activity of streptozotocin.
Topics: Amino Acids; Animals; Diabetes Mellitus; Diaphragm; Diazoxide; Epinephrine; Ethanol; Glucosamine; Glucose; Hyperglycemia; Hypoglycemic Agents; Male; NAD; Niacinamide; Nitroso Compounds; Pyrazinamide; Pyrazines; Pyrazoles; Rats; Tolbutamide | 1969 |
Effect of pyrazinamide on nicotinamide adenine dinucleotide glycohydrolase of tuberculous host.
Topics: Animals; Drug Resistance, Microbial; Isoniazid; Liver; Male; Mice; Mycobacterium Infections; Mycobacterium tuberculosis; N-Glycosyl Hydrolases; NAD; Niacinamide; Pyrazinamide | 1973 |
Effects of cord factor on microsomal enzymes.
Topics: Amidohydrolases; Aminopyrine N-Demethylase; Animals; Cattle; Cytochrome P-450 Enzyme System; Cytochrome Reductases; Cytochromes; Depression, Chemical; Disaccharides; Glucose-6-Phosphatase; Glycolipids; Mice; Microsomes, Liver; Mycobacterium tuberculosis; N-Glycosyl Hydrolases; NAD; Proteins; Pyrazinamide; Trehalose | 1974 |
Poly(adenosinediphosphoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleic acid synthesis in normal human lymphocytes.
Topics: Benzamides; DNA; DNA Repair; Humans; Lymphocytes; Methylnitronitrosoguanidine; NAD; NAD+ Nucleosidase; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Purines; Pyrazinamide | 1982 |
The effect of pyrazines on the metabolism of tryptophan and nicotinamide adenine dinucleotide in the rat. Evidence of the formation of a potent inhibitor of aminocarboxy-muconate-semialdehyde decarboxylase from pyrazinamide.
Topics: Animals; Carboxy-Lyases; Kidney; Liver; Male; NAD; Nicotinic Acids; Poly(ADP-ribose) Polymerases; Pyrazinamide; Pyrazines; Rats; Rats, Inbred Strains; Tryptophan | 1981 |
Pyridine nucleotide levels in liver of rats fed clofibrate- or pyrazinamide-containing diets.
Topics: Animals; Clofibrate; Diet; Female; Hypolipidemic Agents; Liver; Male; NAD; NADP; Pyrazinamide; Rats; Rats, Sprague-Dawley | 1998 |
Effects of dietary pyrazinamide, an antituberculosis agent, on the metabolism of tryptophan to niacin and of tryptophan to serotonin in rats.
Topics: Animals; Antitubercular Agents; Diet; Eating; Liver; Male; NAD; NADP; Niacin; Pyrazinamide; Quinolinic Acid; Rats; Rats, Wistar; Serotonin; Tryptophan; Weight Gain | 2001 |
Growth-promoting activity of pyrazinoic acid, a putative active compound of antituberculosis drug pyrazinamide, in niacin-deficient rats through the inhibition of ACMSD activity.
Topics: Animals; Antitubercular Agents; Carboxy-Lyases; Diet; Eating; Injections, Intraperitoneal; Kidney; Kynurenic Acid; Liver; Male; NAD; Niacin; Pyrazinamide; Rats; Rats, Wistar; Tryptophan; Weight Gain; Xanthurenates | 2002 |
Differential effects of pyrazinamide and clofibrate on gene expression of rat hepatic alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase, a key enzyme of the tryptophan-NAD pathway.
Topics: Analysis of Variance; Animals; Antitubercular Agents; Carboxy-Lyases; Clofibrate; Diet, Fat-Restricted; Diet, Protein-Restricted; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Hypolipidemic Agents; Kidney; Liver; Male; Models, Animal; NAD; Peroxisome Proliferators; Pyrazinamide; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Time Factors; Transcription, Genetic; Tryptophan; Weight Gain | 2006 |
Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics.
Topics: Adenosine Triphosphate; Antitubercular Agents; Drug Interactions; Electron Transport Complex I; Electron Transport Complex III; Energy Metabolism; Hep G2 Cells; Humans; Isoniazid; Lactic Acid; Membrane Potential, Mitochondrial; NAD; Pyrazinamide; Rifampin | 2017 |
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD.
Topics: Antitubercular Agents; Binding Sites; Carbon; Carboxy-Lyases; Coenzyme A; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Models, Molecular; Mycobacterium bovis; Mycobacterium tuberculosis; NAD; Protein Binding; Protein Conformation; Pyrazinamide | 2017 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |